Tumor-Infiltrating Lymphocytes in Triple Negative Breast Cancer: The Future of Immune Targeting

Tumor-Infiltrating Lymphocytes in Triple Negative Breast Cancer: The Future of Immune Targeting

Show other versions (1)

Triple negative breast cancer (TNBC) is a highly heterogeneous tumor. There is increasing evidence of the role of tumor lymphocytic immune infiltrates in this subtype of breast cancer. Robust levels of tumor infiltrating lymphocytes (TILs) have been associated with improved disease-free and overall...

Full description

Bibliographic Details
Main Authors:	Paula García-Teijido, María Luque Cabal, Ignacio Peláez Fernández, Yolanda Fernández Pérez
Format:	Article
Language:	English
Published:	SAGE Publishing 2016-01-01
Series:	Clinical Medicine Insights: Oncology
Online Access:	https://doi.org/10.4137/CMO.S34540

Similar Items

Tumor-Infiltrating Lymphocytes in Triple Negative Breast Cancer: The Future of Immune Targeting
by: Paula García-Teijido, et al.
Published: (2016-04-01)

Tumor-infiltrating lymphocytes in triple negative breast cancer
by: L. M. Zakhartseva, et al.
Published: (2020-12-01)

Immunity and cancer: role of tumor-infiltrating lymphocytes in triple-negative breast cancer
by: Ana Tečić-Vuger, et al.
Published: (2021-01-01)

THE ROLE OF TUMOR-INFILTRATING LYMPHOCYTES IN TRIPLE NEGATIVE BREAST CANCER
by: Anca Zgura, et al.
Published: (2018-09-01)

Systemic immune reaction in axillary lymph nodes adds to tumor-infiltrating lymphocytes in triple-negative breast cancer prognostication
by: Fangfang Liu, et al.
Published: (2021-07-01)

Multi-panel immunofluorescence analysis of tumor infiltrating lymphocytes in triple negative breast cancer: Evolution of tumor immune profiles and patient prognosis.
by: Ting-Fang He, et al.
Published: (2020-01-01)

Association between p53 Expression and Amount of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer
by: Miseon Lee, et al.
Published: (2019-05-01)

Optimized tumour infiltrating lymphocyte assessment for triple negative breast cancer prognostics
by: Maschenka CA. Balkenhol, et al.
Published: (2021-04-01)

Clinicopathological significance of PTEN, Twist1 and PD1+ tumor infiltration lymphocytes in triple negative breast cancer
by: Ran Li, et al.
Published: (2021-06-01)

Predictive value of tumor-infiltrating lymphocytes to pathological complete response in neoadjuvant treated triple-negative breast cancers
by: Miao Ruan, et al.
Published: (2018-08-01)

Correlation Between Mammographic Radiomics Features and the Level of Tumor-Infiltrating Lymphocytes in Patients With Triple-Negative Breast Cancer
by: Hongwei Yu, et al.
Published: (2020-04-01)

Expression of the MHC class II in triple-negative breast cancer is associated with tumor-infiltrating lymphocytes and interferon signaling.
by: In Ah Park, et al.
Published: (2017-01-01)

Prognostic value of tumor-infiltrating lymphocyte subtypes in residual tumors of patients with triple-negative breast cancer after neoadjuvant chemotherapy
by: Yu-Ge Bai, et al.
Published: (2020-03-01)

Histological analysis of gamma delta T lymphocytes infiltrating human triple-negative breast carcinomas
by: Jose Villacorta Hidalgo, et al.
Published: (2014-12-01)

ADAR1 expression is associated with tumour-infiltrating lymphocytes in triple-negative breast cancer
by: In Hye Song, et al.
Published: (2017-10-01)

Secreted breast tumor interstitial fluid microRNAs and their target genes are associated with triple-negative breast cancer, tumor grade, and immune infiltration
by: Thilde Terkelsen, et al.
Published: (2020-06-01)

A Computational Tumor-Infiltrating Lymphocyte Assessment Method Comparable with Visual Reporting Guidelines for Triple-Negative Breast Cancer
by: Peng Sun, et al.
Published: (2021-08-01)

Prognostic value of tumor-infiltrating lymphocytes in patients with triple-negative breast cancer: a systematic review and meta-analysis
by: Guoxuan Gao, et al.
Published: (2020-03-01)

Thrombospondin-1 Silencing Improves Lymphocyte Infiltration in Tumors and Response to Anti-PD-1 in Triple-Negative Breast Cancer
by: Elie Marcheteau, et al.
Published: (2021-08-01)

Level of tumor-infiltrating lymphocytes and PD status as potential prognostic markers of survival and therapy effectiveness in triple-negative breast cancer
by: A. F. Nasretdinov, et al.
Published: (2020-06-01)

Tumor Infiltrating Lymphocytes Affect the Outcome of Patients with Operable Triple-Negative Breast Cancer in Combination with Mutated Amino Acid Classes.
by: Vassiliki Kotoula, et al.
Published: (2016-01-01)

Relation Between CD8+T Lymphocyte Infiltration and Efficacy of Neoadjuvant Chemotherapy for Triple-negative Breast Cancer
by: KONG Tiandong, et al.
Published: (2021-05-01)

Should Tumor Infiltrating Lymphocytes, Androgen Receptor, and FOXA1 Expression Predict the Clinical Outcome in Triple Negative Breast Cancer Patients?
by: Anita Mangia, et al.
Published: (2019-09-01)

Cytotoxic T-lymphocyte infiltration and chemokine predict long-term patient survival independently of tumor mutational burden in triple-negative breast cancer
by: Eriko Katsuta, et al.
Published: (2021-04-01)

Rates of immune cell infiltration in patients with triple-negative breast cancer by molecular subtype.
by: Kenichi Harano, et al.
Published: (2018-01-01)

Plasmacytoid Dendritic Cell (pDC) Infiltration Correlate with Tumor Infiltrating Lymphocytes, Cancer Immunity, and Better Survival in Triple Negative Breast Cancer (TNBC) More Strongly than Conventional Dendritic Cell (cDC)
by: Masanori Oshi, et al.
Published: (2020-11-01)

Tumor-infiltrating B cells and T cells correlate with postoperative prognosis in triple-negative carcinoma of the breast
by: Hajime Kuroda, et al.
Published: (2021-03-01)

Lumpectomy followed by radiation improves survival in HER2 positive and triple‐negative breast cancer with high tumor‐infiltrating lymphocytes compared to mastectomy alone
by: Jason A. Mouabbi, et al.
Published: (2021-07-01)

CXCR2 Levels Correlate with Immune Infiltration and a Better Prognosis of Triple-Negative Breast Cancers
by: Florence Boissière-Michot, et al.
Published: (2021-05-01)

Tumor-Infiltrating Lymphocytes and Breast Cancer: Are Immune Checkpoint Inhibitors Ready for Prime Time in Breast Cancer?
by: Cvetanović Ana, et al.
Published: (2016-12-01)

Ki67 Index Changes and Tumor-Infiltrating Lymphocyte Levels Impact the Prognosis of Triple-Negative Breast Cancer Patients With Residual Disease After Neoadjuvant Chemotherapy
by: Yihua Wang, et al.
Published: (2021-06-01)

Clinicopathological Correlates of γδ T Cell Infiltration in Triple-Negative Breast Cancer
by: Florence Boissière-Michot, et al.
Published: (2021-02-01)

Sphingosine-1-Phosphate Catabolizing Enzymes Predict Better Prognosis in Triple-Negative Breast Cancer Patients and Correlates With Tumor-Infiltrating Immune Cells
by: Rajeev Nema, et al.
Published: (2021-06-01)

Immune Cell Infiltration-Based Characterization of Triple-Negative Breast Cancer Predicts Prognosis and Chemotherapy Response Markers
by: Yufei Lv, et al.
Published: (2021-03-01)

FOXP1 negatively regulates tumor infiltrating lymphocyte migration in human breast cancerResearch in context
by: Pushpamali De Silva, et al.
Published: (2019-01-01)

Impact of the Tumor Microenvironment on Tumor-Infiltrating Lymphocytes: Focus on Breast Cancer
by: Ivan J Cohen, et al.
Published: (2017-09-01)

Tumor analysis: freeze–thawing cycle of triple-negative breast cancer cells alters tumor CD24/CD44 profiles and the percentage of tumor-infiltrating immune cells
by: Matthieu Le Gallo, et al.
Published: (2018-06-01)

Biomolecular Factors Represented by Bcl-2, p53, and Tumor-Infiltrating Lymphocytes Predict Response for Adjuvant Anthracycline Chemotherapy in Patients with Early Triple-Negative Breast Cancer
by: Bacinschi XE, et al.
Published: (2020-11-01)

Bevacizumab improves tumor infiltration of mature dendritic cells and effector T-cells in triple-negative breast cancer patients
by: Yves Boucher, et al.
Published: (2021-06-01)

High Expression of NRF2 Is Associated with Increased Tumor-Infiltrating Lymphocytes and Cancer Immunity in ER-Positive/HER2-Negative Breast Cancer
by: Masanori Oshi, et al.
Published: (2020-12-01)